Arterial Occlusive Diseases Clinical Trial
Official title:
FLEX FIRST Registry Research Protocol
Prospective, observational study evaluating the clinical use and outcomes of the FLEX Vessel Prep (VP) system in arteriovenous fistulae or grafts presenting with clinical or hemodynamic abnormalities following 12 months post treatment.
Status | Recruiting |
Enrollment | 400 |
Est. completion date | February 2024 |
Est. primary completion date | December 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Subject is =18 years of age. 2. Subject is currently scheduled to undergo an endovascular intervention of arteriovenous fistula or graft due to clinical and hemodynamic abnormalities meeting the KDOQI Guidelines for AV access dysfunction: - Elevated venous pressure during hemodialysis, - Abnormal physical findings, and - Unexplained decrease in delivered dialysis dose. 3. Subject has a reasonable expectation of remaining on hemodialysis for =12 months. 4. Subject is legally competent, informed of the study, voluntarily agrees to participate, and signs the informed consent form. 5. Subject understands the study and is willing and able to comply with the follow-up requirements. Exclusion Criteria: 1. Subject has a known or suspected systemic infection. 2. Subject has a known or suspected infection of the hemodialysis graft. 3. Subject has an untreatable allergy to radiographic contrast material. 4. In the opinion of the operating physician, the subject's hemodialysis access is unsuitable for endovascular treatment. |
Country | Name | City | State |
---|---|---|---|
United States | Open Access Vascular Access | Miami | Florida |
United States | Minneapolis Vascular Surgery Center | New Brighton | Minnesota |
United States | Dialysis Access Institute | Orangeburg | South Carolina |
United States | Spartanburg Regional Health | Spartanburg | South Carolina |
Lead Sponsor | Collaborator |
---|---|
VentureMed Group Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Target Lesion Primary Patency Rate | Defined as freedom from clinically driven target lesion re-intervention (CD-TLR) or access circuit thrombosis measured through 6-months post- procedure. | 6 months post procedure | |
Primary | Serious Adverse Event Rate | Defined as the Serious Adverse Event (SAE) rate involving the AV access circuit through 1-month post-procedure. | 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03724279 -
Crossing Atheroma or Thrombus With ByCross Device for Revascularization of Peripheral Arteries of Diameter ≥ 3mm
|
N/A | |
Recruiting |
NCT04390672 -
Multivessel TALENT
|
N/A | |
Not yet recruiting |
NCT02841488 -
Ischemic Pain Control With Analgesic Methods Clinical Trial
|
Phase 3 | |
Completed |
NCT00371371 -
Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)
|
Phase 1/Phase 2 | |
Completed |
NCT00174759 -
CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease
|
Phase 3 | |
Completed |
NCT00209443 -
A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide
|
Phase 3 | |
Completed |
NCT00000539 -
Arterial Disease Multifactorial Intervention Trial (ADMIT)
|
Phase 3 | |
Recruiting |
NCT04089943 -
The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD
|
N/A | |
Recruiting |
NCT04343209 -
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)
|
||
Not yet recruiting |
NCT05930145 -
Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke
|
N/A | |
Recruiting |
NCT04142021 -
Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coronary CTA and FFRCT in Patients With Complex Coronary Artery Disease (FASTTRACK CABG)
|
||
Completed |
NCT03253692 -
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
|
||
Active, not recruiting |
NCT04624854 -
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
|
Phase 4 | |
Active, not recruiting |
NCT02921230 -
Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery
|
N/A | |
Recruiting |
NCT02593994 -
IRIS-Onyx Cohort in the IRIS-DES Registry
|
||
Completed |
NCT02008097 -
Clinical Benefits of B-Flow Ultrasound
|
N/A | |
Terminated |
NCT01462721 -
The eSVS® Mesh Randomized Post-Market Study
|
N/A | |
Completed |
NCT00282646 -
Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD)
|
Phase 2 | |
Not yet recruiting |
NCT04956523 -
Preliminary Tissue Monitoring During Endovascular Intervention Study
|
||
Not yet recruiting |
NCT04175197 -
LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries
|